ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.760
+0.030 (1.73%)
Nov 21, 2024, 4:00 PM EST - Market closed
ESSA Pharma Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 85.99 | 33.7 | 57.08 | 137.83 | 56.32 | 53.32 | Upgrade
|
| Short-Term Investments | 44.71 | 114.37 | 110.16 | 57.1 | 22.01 | - | Upgrade
|
| Cash & Short-Term Investments | 130.69 | 148.08 | 167.24 | 194.93 | 78.33 | 53.32 | Upgrade
|
| Cash Growth | -14.28% | -11.46% | -14.21% | 148.85% | 46.90% | 259.58% | Upgrade
|
| Other Receivables | 0.18 | 0.14 | 0.01 | 0.49 | 0.31 | 0.36 | Upgrade
|
| Receivables | 0.18 | 0.14 | 0.01 | 0.49 | 0.31 | 0.36 | Upgrade
|
| Prepaid Expenses | 0.91 | 0.21 | 1.79 | 1.99 | 1.48 | 0.53 | Upgrade
|
| Other Current Assets | 0.31 | 0.38 | 0.02 | 0.19 | 0.18 | 0.08 | Upgrade
|
| Total Current Assets | 132.09 | 148.8 | 169.06 | 197.6 | 80.3 | 54.3 | Upgrade
|
| Property, Plant & Equipment | 0.32 | 0.07 | 0.19 | 0.31 | - | - | Upgrade
|
| Other Long-Term Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.28 | 0.27 | Upgrade
|
| Total Assets | 132.67 | 149.12 | 169.51 | 198.17 | 80.57 | 54.57 | Upgrade
|
| Accounts Payable | 1.91 | 2.03 | 0.95 | 1.43 | 0.68 | 1.36 | Upgrade
|
| Accrued Expenses | 1.55 | 1.39 | 1.22 | 2.38 | 0.47 | 0.21 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 3.71 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.08 | 0.13 | 0.12 | 0.06 | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0.3 | Upgrade
|
| Total Current Liabilities | 3.58 | 3.5 | 2.31 | 3.93 | 1.2 | 5.57 | Upgrade
|
| Long-Term Leases | 0.23 | - | 0.08 | 0.21 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.02 | 0.13 | 0.02 | Upgrade
|
| Total Liabilities | 3.8 | 3.5 | 2.39 | 4.16 | 1.33 | 5.59 | Upgrade
|
| Common Stock | 279.75 | 278.16 | 278.09 | 277.42 | 131.09 | 78.55 | Upgrade
|
| Additional Paid-In Capital | 52.86 | 49.05 | 44.04 | 36.44 | 31.2 | 30.04 | Upgrade
|
| Retained Earnings | -201.65 | -179.46 | -152.88 | -117.78 | -80.97 | -57.52 | Upgrade
|
| Comprehensive Income & Other | -2.1 | -2.12 | -2.14 | -2.08 | -2.08 | -2.08 | Upgrade
|
| Total Common Equity | 128.86 | 145.63 | 167.12 | 194.01 | 79.24 | 48.98 | Upgrade
|
| Shareholders' Equity | 128.86 | 145.63 | 167.12 | 194.01 | 79.24 | 48.98 | Upgrade
|
| Total Liabilities & Equity | 132.67 | 149.12 | 169.51 | 198.17 | 80.57 | 54.57 | Upgrade
|
| Total Debt | 0.34 | 0.08 | 0.21 | 0.33 | 0.06 | 3.71 | Upgrade
|
| Net Cash (Debt) | 130.35 | 148 | 167.03 | 194.6 | 78.27 | 49.61 | Upgrade
|
| Net Cash Growth | -14.44% | -11.39% | -14.17% | 148.61% | 57.76% | 482.86% | Upgrade
|
| Net Cash Per Share | 2.95 | 3.36 | 3.79 | 5.06 | 3.49 | 5.88 | Upgrade
|
| Filing Date Shares Outstanding | 44.37 | 44.14 | 44.07 | 43.98 | 33.6 | 20.76 | Upgrade
|
| Total Common Shares Outstanding | 44.37 | 44.1 | 44.07 | 43.98 | 32.06 | 20.76 | Upgrade
|
| Working Capital | 128.52 | 145.3 | 166.75 | 193.67 | 79.09 | 48.72 | Upgrade
|
| Book Value Per Share | 2.90 | 3.30 | 3.79 | 4.41 | 2.47 | 2.36 | Upgrade
|
| Tangible Book Value | 128.86 | 145.63 | 167.12 | 194.01 | 79.24 | 48.98 | Upgrade
|
| Tangible Book Value Per Share | 2.90 | 3.30 | 3.79 | 4.41 | 2.47 | 2.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.